NZ590011A - Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof - Google Patents

Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof

Info

Publication number
NZ590011A
NZ590011A NZ590011A NZ59001108A NZ590011A NZ 590011 A NZ590011 A NZ 590011A NZ 590011 A NZ590011 A NZ 590011A NZ 59001108 A NZ59001108 A NZ 59001108A NZ 590011 A NZ590011 A NZ 590011A
Authority
NZ
New Zealand
Prior art keywords
seq
acetyl transferase
chloramphenicol acetyl
cat
fusion protein
Prior art date
Application number
NZ590011A
Other languages
English (en)
Inventor
Andrew R Mendelsohn
Keith N Haffer
James Larrick
Original Assignee
Braasch Biotech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braasch Biotech Llc filed Critical Braasch Biotech Llc
Priority to NZ590011A priority Critical patent/NZ590011A/xx
Publication of NZ590011A publication Critical patent/NZ590011A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01028—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NZ590011A 2008-06-25 2008-06-25 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof NZ590011A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ590011A NZ590011A (en) 2008-06-25 2008-06-25 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ590011A NZ590011A (en) 2008-06-25 2008-06-25 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
PCT/US2008/068195 WO2009157926A1 (en) 2008-06-25 2008-06-25 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof

Publications (1)

Publication Number Publication Date
NZ590011A true NZ590011A (en) 2012-09-28

Family

ID=41444809

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ590011A NZ590011A (en) 2008-06-25 2008-06-25 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof

Country Status (15)

Country Link
US (3) US7722881B2 (https=)
EP (1) EP2303314B1 (https=)
JP (1) JP5506792B2 (https=)
KR (1) KR101555731B1 (https=)
CN (1) CN102105163B (https=)
AU (1) AU2008358353B2 (https=)
CA (1) CA2728734A1 (https=)
DK (1) DK2303314T3 (https=)
ES (1) ES2445403T3 (https=)
IL (1) IL209792A (https=)
MX (1) MX2010014082A (https=)
NZ (1) NZ590011A (https=)
RU (1) RU2501565C2 (https=)
WO (1) WO2009157926A1 (https=)
ZA (1) ZA201009125B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303314B1 (en) 2008-06-25 2013-12-11 Braasch Biotech LLC Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof in cattle
NZ590010A (en) 2008-06-25 2013-01-25 Braasch Biotech Llc Compositions and methods treating growth hormone deficiency and/or an insulin-like growth factor 1 deficiency with somatostatin and an adjuvant
SG11201408287RA (en) * 2012-06-26 2015-01-29 Biovalence Sdn Bhd Rapid specific pathogen free animal
MX365599B (es) 2012-11-08 2019-06-07 Phi Pharma Sa Moleculas de transporte especificas de proteoglicano c4s.
RU2526571C1 (ru) * 2013-04-08 2014-08-27 Сергей Михайлович Юдин Инъекционный препарат для повышения спермопродукции человека и способ его применения
US10441652B2 (en) * 2014-08-21 2019-10-15 Braasch Biotech Llc Methods for improving immunological response in vaccinated animals
WO2021024020A1 (en) 2019-08-06 2021-02-11 Astellas Pharma Inc. Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer
JP7727389B2 (ja) * 2020-02-11 2025-08-21 ブラッシュ・バイオテック・エルエルシー 乳房炎の処置及び／又は予防のための組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
ATE163013T1 (de) 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
RU2034457C1 (ru) * 1993-06-22 1995-05-10 Товарищество с ограниченной ответственностью "Ветек" Способ повышения продуктивности сельскохозяйственных животных и препарат для его осуществления
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US20070048860A1 (en) * 1997-10-10 2007-03-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Carcinoembryonic antigen (CEA) peptides
PL213561B1 (pl) 2004-01-09 2013-03-29 Inst Biotechnologii I Antybiotykow Sposób otrzymywania plazmidu, plazmid oraz zastosowania
US7998930B2 (en) * 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
ZA200711123B (en) * 2005-06-27 2009-08-26 Biovail Lab Int Srl Modified-release formulations of a bupropion salt
EP2303314B1 (en) * 2008-06-25 2013-12-11 Braasch Biotech LLC Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof in cattle
NZ590010A (en) 2008-06-25 2013-01-25 Braasch Biotech Llc Compositions and methods treating growth hormone deficiency and/or an insulin-like growth factor 1 deficiency with somatostatin and an adjuvant

Also Published As

Publication number Publication date
AU2008358353A1 (en) 2009-12-30
ES2445403T3 (es) 2014-03-03
EP2303314A4 (en) 2012-07-18
US20100136037A1 (en) 2010-06-03
US7722881B2 (en) 2010-05-25
ZA201009125B (en) 2012-06-27
IL209792A0 (en) 2011-02-28
CN102105163B (zh) 2014-12-10
US20090324629A1 (en) 2009-12-31
JP2011525914A (ja) 2011-09-29
MX2010014082A (es) 2011-04-07
DK2303314T3 (da) 2014-01-13
CA2728734A1 (en) 2009-12-30
AU2008358353B2 (en) 2013-11-07
EP2303314B1 (en) 2013-12-11
BRPI0822826A2 (pt) 2015-07-07
IL209792A (en) 2012-12-31
RU2501565C2 (ru) 2013-12-20
US8367073B2 (en) 2013-02-05
EP2303314A1 (en) 2011-04-06
KR101555731B1 (ko) 2015-09-25
WO2009157926A1 (en) 2009-12-30
CN102105163A (zh) 2011-06-22
US7943143B2 (en) 2011-05-17
RU2011100104A (ru) 2012-07-20
JP5506792B2 (ja) 2014-05-28
US20120076806A1 (en) 2012-03-29
KR20110039517A (ko) 2011-04-19

Similar Documents

Publication Publication Date Title
NZ590011A (en) Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof
NZ600690A (en) Fkbp-l and uses thereof
NZ595499A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
ES2553331T3 (es) Nuevos genes marcadores seleccionables
NZ596764A (en) N-glycan core beta-galactosyltransferase and uses thereof
NZ598351A (en) Il-17 binding compounds and medical uses thereof
RU2007141683A (ru) Вариантная форма урат-оксидазы и ее использование
WO2004099228A3 (en) Variants of beta-glucosidases
NZ604915A (en) Recombinant production of steviol glycosides
WO2007144190A3 (en) Plants with modulated expression of nac transcription factors having enhanced yield-related traits and a method for making the same
NZ591612A (en) Prevention, treatment and diagnosis of p.gingivalis infection with peptides
NZ580378A (en) Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
UA98620C2 (uk) Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2
WO2009047992A1 (ja) Ｕｄｐ－グルクロン酸転移酵素およびそれをコードするポリヌクレオチド
NZ609216A (en) Anticancer fusion protein
PE20090683A1 (es) Peptidos de senalizacion
MX351107B (es) Acidos nucleicos que se enlazan con mcp-1.
NZ593893A (en) Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
WO2010007144A3 (en) Mutated netrin-4 proteins, fragments thereof and their uses as drugs
WO2010026219A3 (en) New tomato ethylene response factors and uses thereof
MX2009007261A (es) Vacuna de peptido foxp3.
WO2008113536A8 (en) Neurotrophic peptides
WO2008087224A3 (en) Mutated netrin 4, fragments thereof and uses thereof as drugs
WO2010057242A3 (de) Vakzin
CY1111630T1 (el) Παραγωγα κυτοκινων

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: BRAASCH BIOTECH LLC, US

Free format text: OLD OWNER(S): BRAASCH BIOTECH LLC; ANDREW R MENDELSOHN; KEITH N HAFFER; JAMES LARRICK

S883 Correction of error according to section 88(3) (mistake in register caused on part of patentee or applicant)

Free format text: CORRECTION TO APPLICANT (71)

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 25 JUN 2015 BY AJ PARK

Effective date: 20130502

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JUN 2016 BY THOMSON REUTERS

Effective date: 20150514

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JUN 2017 BY THOMSON REUTERS

Effective date: 20160512

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JUN 2018 BY THOMSON REUTERS

Effective date: 20170527

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JUN 2019 BY CPA GLOBAL

Effective date: 20180510

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JUN 2020 BY CPA GLOBAL

Effective date: 20190509

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JUN 2021 BY CPA GLOBAL

Effective date: 20200514

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 JUN 2022 BY CPA GLOBAL

Effective date: 20210513

LAPS Patent lapsed